Results 11 to 20 of about 1,541,059 (150)

Evaluation of the aMAP score for hepatocellular carcinoma surveillance: a realistic opportunity to risk stratify [PDF]

British Journal of Cancer, 2022
Abstract Background and aims The aMAP score is a model that predicts risk of hepatocellular carcinoma (HCC) development in patients with chronic hepatitis. Its performance in a ‘real world’ surveillance setting has not yet been ascertained. Patients and methods We had access
David Hughes, Hidenori Toyoda, Hamish Innes   +2 more
exaly   +7 more sources

The aMAP Score is an Independent Risk Factor for Intermediate-stage Hepatocellular Carcinoma: A Large Retrospective Cohort Study [PDF]

Journal of Cancer, 2023
Background: A less effective nomogram for patients with intermediate-stage hepatocellular carcinoma (HCC) to predict overall survival (OS) is available. This study aimed to investigate the role of age-male-albumin-bilirubin-platelet (aMAP) scores in the prognosis of patients with intermediate-stage HCC and develop an aMAP score-based nomogram to ...
Qin Lin
exaly   +4 more sources

Validation of the aMAP score to predict hepatocellular carcinoma development in a cohort of alcohol‐related cirrhosis patients [PDF]

Liver Cancer International, 2022
AbstractBackground and AimsThe aMAP score was recently devised to predict hepatocellular carcinoma (HCC) development. However, its performance was not tested in alcohol‐related cirrhosis (ALC). We aimed to validate the aMAP score in a cohort of ALC patients.MethodStudy participants with ALC from a prior genome‐wide association study were included.
Ken Liu, Terry C. F. Yip, Steven Masson, Waleed Fateen, Tae‐Hwi Schwantes‐An, Geoffrey W. McCaughan, Timothy R. Morgan, Guruprasad P. Aithal, Devanshi Seth   +8 more
openaire   +2 more sources

Using the aMAP Risk Score to Predict Late Recurrence Following Radiofrequency Ablation for Hepatocellular Carcinoma in Chinese Population: A Multicenter Study

Journal of Hepatocellular Carcinoma, 2021
Yi Yang, 1,* Yanzhao Zhou, 2, 3,* Xinyuan Zhang, 1,* Yujing Xin, 1 Yi Chen, 1, 4 Qingsheng Fan, 5 Xiao Li, 1 Xi Wei, 6 Qiang Li, 3 Xiang Zhou, 1 Jinxue Zhou 2 1Department of Interventional Therapy, National Cancer Center/National Clinical Research ...
Yang Y, Zhou Y, Zhang X, Xin Y, Chen Y, Fan Q, Li X, Wei X, Li Q, Zhou X, Zhou J   +10 more
doaj   +4 more sources

Combining the FIB-4 Index with the aMAP Score to Enhance Prediction of Liver Carcinogenesis in HCV-SVR Patients [PDF]

Combining the FIB-4 Index with the aMAP Score to Enhance Prediction of Liver Carcinogenesis in HCV-SVR Patients
Background and aim: The background of liver carcinogenesis has shifted from viral hepatitis to sustained virological response (SVR) of hepatitis C virus (HCV) due to the advent of direct-acting antiviral agents (DAAs). The aMAP score is useful for predicting liver carcinogenesis in HCV-SVR patients, but limitations remain, particularly in medium- and ...
Masaoka, Rion, Shirahashi, Ryosaku, Kusano, Yumi, Soma, Yuki, Sakakibara, Kazuma, Yamada, Sotarou, Soga, Koichi, Tamano, Masaya   +7 more
core   +4 more sources

Development of a longitudinal predictive model for hepatocellular carcinoma occurrence in patients with chronic hepatitis B [PDF]

Scientific Reports
Hepatocellular carcinoma (HCC) remains a major cause of morbidity and mortality among patients with chronic hepatitis B (CHB). Existing HCC risk scores are largely based on baseline variables and do not account for longitudinal changes over time.
Apichat Kaewdech, Chanavee Toh, Pimsiri Sripongpun, Naichaya Chamroonkul, Pisit Tangkijvanich, Teerha Piratvisuth, Suthat Liangpunsakul, Paramee Thongsuksai, Thammasin Ingviya   +8 more
doaj   +2 more sources

The Age-Male-Albumin-Bilirubin-Platelets (aMAP) Risk Score Predicts Liver Metastasis Following Surgery for Breast Cancer in Chinese Population: A Retrospective Study

ImmunoTargets and Therapy
Li Chen,1,2,* Qiang Liu,2,* Chunlei Tan,3,* Tiangen Wu,4,* Meng Wu,5 Xiaosheng Tan,5 Jinwen Liu,1 Jing Wang2 1Department of Thyroid and Breast Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology,
Chen L, Liu Q, Tan C, Wu T, Wu M, Tan X, Liu J, Wang J   +7 more
doaj   +3 more sources

[Application of aMAP score to assess the risk of hepatocarciongenesis in population of chronic liver disease in primary hospitals]. [PDF]

Zhonghua Gan Zang Bing Za Zhi, 2021
Objective: The aMAP score is a hepatocellular carcinoma (HCC) risk prediction model based on an international cooperative cohort, which can be applied to various liver diseases. The aim of this study is to use the aMAP score to stratify the risk of HCC in patients with chronic liver disease (combined or non-combined metabolic diseases) admitted to ...
Li XH, Hao X, Deng YH, Liu XQ, Liu HY, Zhou FY, Fan R, Guo YB, Hou JL.   +8 more
europepmc   +3 more sources

Validation of Noninvasive Markers for HCC Risk Stratification in 1389 Patients With Biopsy-proven NAFLD

Gastro Hep Advances, 2023
Background and Aims: Nonalcoholic fatty liver diseases (NAFLD) and nonalcoholic steatohepatitis (NASH) can cause hepatocellular carcinoma (HCC). We examined histological features and reported noninvasive markers/models for stratifying the risk of HCC ...
Hidenori Toyoda, Hideki Fujii, Michihiro Iwaki, Hideki Hayashi, Satoshi Oeda, Hideyuki Hyogo, Miwa Kawanaka, Asahiro Morishita, Kensuke Munekage, Kazuhito Kawata, Sakura Yamamura, Koji Sawada, Tatsuji Maeshiro, Hiroshi Tobita, Yuichi Yoshida, Masafumi Naito, Asuka Araki, Shingo Arakaki, Takumi Kawaguchi, Hidenao Noritake, Masafumi Ono, Tsutomu Masaki, Satoshi Yasuda, Eiichi Tomita, Masato Yoneda, Norifumi Kawada, Akihiro Tokushige, Yoshihiro Kamada, Hirokazu Takahashi, Shinichiro Ueda, Shinichi Aishima, Yoshio Sumida, Atsushi Nakajima, Takeshi Okanoue   +33 more
doaj   +1 more source

IDDF2021-ABS-0137 The aMAP score predicts risk of hepatocellular carcinoma development in patients with alcohol-related cirrhosis [PDF]

Clinical Hepatology, 2021
Background The aMAP score (derived from age, male sex, albumin and platelet count) was recently devised to predict hepatocellular carcinoma (HCC) development. It was shown to have excellent performance irrespective of aetiology and ethnicity. Only one cohort of non-viral hepatitis patients (Japanese with mostly non-alcoholic fatty liver disease) was ...
Ken Liu, Steven Masson, Waleed Fateen, Guruprasad Aithal, Terry CF Yip, Devanshi Seth   +5 more
openaire   +1 more source